Your browser version may not work well with NCBI's Web applications. More information here...
1: Urology. 2001 Apr;57(4 Suppl 1):68-72.Click here to read Links

Selective estrogen receptor modulators for the chemoprevention of prostate cancer.

Steiner MS, Raghow S, Neubauer BL.

Department of Urology, University of Tennessee, Memphis, Tennessee 38104, USA. MSteiner@utmem.edu

The ability to interfere with prostate carcinogenesis, and as a consequence, prevent prostate cancer with drugs is the basis for chemoprevention. The prostate contains estrogen receptors in both the stroma and epithelium. Both animal models and human epidemiologic studies have implicated estrogens as an initiator of prostate cancer. In the aging male, prostate cancer occurs in an environment of rising estrogen and decreasing androgen levels. Selective estrogen receptor modulators (SERMs) have shown the ability to prevent (GTx-006 [acapodene]) and treat (GTx-006 and arzoxifene) prostate cancer, suggesting that they may be used in prostate cancer chemoprevention. A phase 2 clinical trial using GTx-006 for prostate cancer chemoprevention is currently being conducted.

PMID: 11295598 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Estrogen (Cenestin® , Enjuvia® , Estrace® , ...)

    Estrogen is used to treat hot flushes ('hot flashes'; sudden strong feelings of heat and sweating) in women who are experiencing menopause ('change of life', the end of monthly menstrual periods). Some brands of estrogen...

  • Tamoxifen (Nolvadex® )

    Your doctor has prescribed tamoxifen for you. Tamoxifen comes as a tablet to take by mouth.

  • Source: AHFS Consumer Medication Information